Bandingkan Harga & Kinerja Indofarma Tbk. (INAF) vs Multistrada Arah Sarana Tbk. (MASA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indofarma Tbk. dan Multistrada Arah Sarana Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Multistrada Arah Sarana Tbk. diperdagangkan di Rp6.200 (kapitalisasi pasar 56,93 T). Perbedaan utamanya: Multistrada Arah Sarana Tbk. jauh lebih besar — sekitar 145,8× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | MASA | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 56,93 T |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →Tentang Multistrada Arah Sarana Tbk.
Multistrada Arah Sarana, PT (the company) was established under its original name of PT Oroban Perkasa on Jun 20th 1988. The company starts commercial operation in 1995. The articles of association have been amended several times, most recently on January 31, 2005, concerning public offering.
Selengkapnya di halaman MASA →
